GlobalRPh Renal Dosing Masterv6.6
Source review / handoff

Desloratadine

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

GlobalRPh RX List - Clarinex

Product / population
Adult desloratadine single-agent tablets. Pediatric renal dose not established.
Renal method
Renal impairment stated qualitatively; no CrCl cutoff supplied.
Source revision
Source revision date not established in selected retrieval.
Retrieved
2026-09-07
Local review status
Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.
Rxlist

GlobalRPh RX List - Clarinex

Open original reference

GlobalRPh-hosted RX List · Adult desloratadine single-agent tablets. Pediatric renal dose not established.

Renal method: Renal impairment stated qualitatively; no CrCl cutoff supplied.
Source date: Source revision date not established in selected retrieval.
Retrieved: 2026-09-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected source text imported locally; independent clinical review pending. Not a complete prescribing monograph.

Renal dosing, restrictions and evidence limits

For adults with renal impairment, the recommended starting dose is one 5-mg tablet every other day. The source does not assign numerical renal bands to this instruction. A renal dosing recommendation for children cannot be made because of insufficient data. Do not extend the adult every-other-day schedule to pediatric patients or combination decongestant products.

RDM34-rxlist-clarinex-drug-C1 · Source locator: Dosage: adults with hepatic or renal impairment.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/clarinex-drug/
Retrieved
2026-09-07
Renal-function method
Renal impairment stated qualitatively; no CrCl cutoff supplied.
Source date/version
Source revision date not established in selected retrieval.
Hash meaning
SHA-256 of local authored summary only, not original HTML, PDF or SPL bytes.
Local summary SHA-256
490fe045448a8ffcdfdcae0673803ad72b78704414a3e847a978ad2f2508e5f5

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=desloratadine&s1=RDM34-rxlist-clarinex-drug&h1=9e2901bc76c059f48088f5c85ddf930ef4ad9f1a58efe5ce4ee82fe7e461b554